Peter Jeffrey Conn
Directeur/Bestuurslid bij Appello Pharmaceuticals, Inc.
Actieve functies van Peter Jeffrey Conn
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Appello Pharmaceuticals, Inc.
 Appello Pharmaceuticals, Inc. BiotechnologyHealth Technology Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN. | Directeur/Bestuurslid | - | - |
Loopbaan van Peter Jeffrey Conn
Eerdere bekende functies van Peter Jeffrey Conn
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| KARA THER | Oprichter | 01-07-2009 | - |
Statistieken
Internationaal
| Verenigde Staten | 3 |
Operationeel
| Founder | 1 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA. | Health Technology |
Appello Pharmaceuticals, Inc.
Appello Pharmaceuticals, Inc. BiotechnologyHealth Technology Appello Pharmaceuticals, Inc. operates as a preclinical-stage company focused on advancing novel positive allosteric modulators of mGlu4 for the treatment of Parkinson’s disease. The company is headquartered in Nashville, TN. | Health Technology |
- Beurs
- Insiders
- Peter Jeffrey Conn
- Ervaring
